Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.040 | 1.000 | 4 | 2012 | 2015 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Cardiovascular Diseases | 0.020 | 0.500 | 2 | 2014 | 2015 | |||||||
|
0.925 | 0.160 | 7 | 24283588 | upstream gene variant | G/T | snv |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2011 | 2016 | ||||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.695 | 0.400 | 7 | 24283791 | upstream gene variant | T/C | snv | 0.48 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
7 | 24282719 | upstream gene variant | T/C | snv | 0.42 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
0.925 | 0.160 | 7 | 24283588 | upstream gene variant | G/T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.120 | 7 | 24291867 | downstream gene variant | A/G | snv | 5.3E-02 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.120 | 7 | 24291867 | downstream gene variant | A/G | snv | 5.3E-02 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 |